IEQ Capital’s ALX Oncology ALXO Stock Holding History

IEQ Capital’s Portfolio ALXO Stock Details ALXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$185K	Hold	92,233	–	–	﹤0.01%	1713
2025 Q4	$104K	Hold	92,233	–	–	﹤0.01%	1758
2025 Q3	$169K	Buy	+92,233	New	+$79.9K	﹤0.01%	1704

Other funds holding ALXO

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

IEQ Capital's ALXO Position: Q1 2026 in Review

IEQ Capital held its ALX Oncology (ALXO) position steady in Q1 2026 at 92,233 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #1713.

IEQ Capital first reported a position in ALXO in Q3 2025 and has held it in 3 quarters since. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

IEQ Capital held 92,233 shares of ALX Oncology worth $185K as of Q1 2026.
IEQ Capital left its ALX Oncology share count unchanged in Q1 2026.
ALX Oncology made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1713 holding.
IEQ Capital first reported a position in ALX Oncology in Q3 2025 and has held it in 3 quarters since.
69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.